Zacks Investment Research
12 Jun 2026, 22:50 UTC · 3h ago
Why Cameco (CCJ) Outpaced the Stock Market Today
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
12 Jun 2026, 22:50 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Cameco's upcoming quarterly EPS is projected to be $0.36, representing a 29.41% decrease year-over-year. — A significant projected drop in earnings typically triggers negative sentiment and downward price pressure.
-0.60Cameco's projected quarterly revenue of $534.36 million is down 15.69% compared to the same period last year. — Declining revenue growth suggests a contraction in business performance or lower uranium pricing/demand.
-0.50Cameco currently holds a Forward P/E ratio of 75.45, a substantial premium compared to its industry average of 17.58. — Extreme overvaluation relative to peers increases the risk of a price correction if earnings do not meet high expectations.
-0.40Continue reading
6 related stories
Search tags
Cameco's full-year earnings per share are projected to grow by 27.18% to $1.31. — Strong full-year growth projections provide a positive long-term counterbalance to short-term quarterly declines.
Which stocks this story touches
The company faces projected earnings and revenue declines compared to the previous year, alongside a high P/E ratio relative to its industry.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
3h ago
